Sang Lee is a Gastroenterology physician. ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
90 S Bedford Rd
Care Mount Medical Pc
Mount Kisco, NY 105493412
Telephone
914-232-3135Registry record last updated 11 Nov 2016.
Clinical trials
- Hand Assisted Versus "Pure" Laparoscopic Assisted Proctectomy for Rectal Cancer
Sponsor: Weill Medical College of Cornell University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20252 payments
- Takeda Pharmaceuticals U.S.A., Inc.Program year20251 payment
- GENZYME CORPORATIONProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
91.4%Proton pump inhibitor72%Omeprazole63%Pantoprazole Sodium26%Dexlansoprazole Dr8%Esomeprazole Magnesium4%Part D<11 patientsH2 blocker5.6%Famotidine100%Part D≥17 patients+ 4 more classes in this area
Cancer & immunology
3.5%Integrin Receptor Antagonist3.5%Entyvio100%Part D<11 patientsAnti-infectives
3%Nucleoside and nucleotide reverse transcriptase inhibitors1.6%Vemlidy100%Part D<11 patientsGlycopeptide Antibacterial1.4%Vancomycin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
8 NIH research awards on record, funded 2004–2026 per NIH RePORTER. The latest:
- Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
Weill Medical Coll of Cornell Univ
FY2026$776,035R01AG078613 - Molecular and Synaptic Mechanisms of Neurotrophin-glutamate Crosstalk
Weill Medical Coll of Cornell Univ
FY2026$542,490R01NS126590 - Molecular and Synaptic Mechanisms of Neurotrophin-glutamate Crosstalk
Weill Medical Coll of Cornell Univ
FY2025$542,490R01NS126590
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Charles Rice, MD
The Rockefeller University
Edward Loftus, MD
Mayo Clinic Rochester
Naga Chalasani, MD
Indiana University School of Medicine
Bruce Sands, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”